Summit Therapeutics Inc Forecast and Target Price

Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $32.59. This median of share price forecast represents a 55.17% upside from the latest price of $21 as on 20.10.25.

Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 20.10.25, the difference is -37.12%